South Africadeterminantsinterventionsreviewvaccine confidencevaccine hesitancyIntroduction: Acceptance of COVID-19 vaccines is critical to personal health, protecting vulnerable populations, reopening socio-economic life, and achieving population health and safety through immunity. The primary aim of this review...
South Africa has approved the COVID-19 vaccine produced by the Chinese company, Sinovac. 2.5 million doses have been cleared for delivery, as South Africa battles a crippling third wave, which is overwhelming hospitals - especially in Johannesburg. The country reported 24,000 new...
A prominent scientist has expressed deep concern that a new vaccine only worked on half of those patients who received it in a trial in South Africa. The Novavax vaccine had nearly 90% success rate in the UK, but only 49,4% efficacy in a smaller test in South Africa. Prof Salim ...
The lead researcher on the trial of the Oxford vaccine carried out in South Africa, Professor Shabir Madhi, told CBS News on Monday that more than 13 variants of the coronavirus had been identified in the country since the start of the pandemic. He said the new one, 501.V2, which has s...
. 18 (Xinhua) -- South Africa's biotechnology company Afrigen Biologics and Vaccines (Afrigen) on Friday confirmed that it seeks to develop a second-generation COVID-19 vaccine that contains less mRNA but with better thermostability, after successfully developing its own mRNA COVID-19 vaccine....
While the vaccine is known globally as Sinopharm, it will be referred to as MC Pharma in South Africa as international companies have to use a local company when applying to SAHPRA for authorization of their vaccine. SAHPRA has also registered the Pfizer vaccine shot Comirnaty, which was initi...
Pfizer said last week, meanwhile, that the vaccine it's developed with German partner BioNTech, which uses the same mRNA technology as Moderna's drug,would likely work against the U.K. variant. The data Pfizer cited did not include testing against the strain prevalent in South Africa. ...
In February 2021, as the first COVID-19 vaccinations were rolled out to healthcare workers in South Africa, there was a renewed sense of hope in the fight against SARS-CoV-2. At the time there were concerns around vaccine procurement and inequity in vacc
In South Africa, the new variant now causes more than 90% of new cases and is more infectious than the original virus. On volunteers who are HIV-positive, preliminary studies in South Africa show the Novavax vaccine appears to be 60% effective. That has been welcomed in a country where ...
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials Introduction Shortly after the emergence of a novel coronavirus towards the end of 2019, the virus was named SARS-CoV-2 by the WHO, and the corresponding disease was termed coronavirus disease (COVID-19)...